CoChat

miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1

Open access
Liu, Yanqing, Liu, Rui, Yang, Fei, Cheng, Rongjie, Chen, Xiaorui, Cui, Shufang, Gu, Yuanyuan, Sun, Wu, You, Chaoying, Liu, Zhijian, Sun, Feng, Wang, Yanbo, Fu, Zheng, Ye, Chao, Zhang, Chenyu, Li, Jing, Chen, Xi · 2017 · Molecular Cancer
Cited by 176

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Colorectal cancer (CRC) is a major worldwide health problem due to its high prevalence and mortality rate. T-cell intracellular antigen 1 (TIA1) is an important tumor suppressor involved in many aspects of carcinogenesis and cancer development. How TIA1 expression is regulated during CRC development remains to be carefully elucidated. METHODS: In CRC tissue sample pairs, TIA1 protein and mRNA levels were monitored by Western blot and qRT-PCR, respectively. Combining meta-analysis and miRNA target prediction software, we could predict microRNAs that targeted TIA1. Next, three CRC cell lines (SW480, Caco2 and HT29) were used to demonstrate the direct targeting of TIA1 by miR-19a. In addition, we investigated the biological effects of TIA1 inhibition by miR-19a both in vitro by CCK-8, EdU, Transwell, Ki67 immunofluorescence and Colony formation assays and in vivo by a xenograft mice model. RESULTS: In colorectal cancer (CRC), we found that TIA1 protein, but not its mRNA, was downregulated. We predicted that TIA1 was a target of miR-19a and validated that miR-19a binded directly to the 3'-UTR of TIA1 mRNA. miR-19a could promote cell proliferation and migration in CRC cells and accelerated tumor growth in xenograft mice by targeting TIA1. CONCLUSIONS: This study highlights an oncomiR role for miR-19a in regulating TIA1 in CRC and suggests that miR-19a may be a novel molecular therapeutic target for CRC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12943-017-0625-8

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 176

Metadata

Authors
Liu, Y., Liu, R., Yang, F., Cheng, R., Chen, X., Cui, S., Gu, Y., Sun, W., You, C., Liu, Z., Sun, F., Wang, Y., Fu, Z., Ye, C., Zhang, C., Li, J., & Chen, X.
Venue
Molecular Cancer
Published
2017-03-04
Volume
16
Issue
1
Pages
53-53
ISSN
1476-4598 (ISSN-L)
OpenAlex
W2594277674
Cited by
176
References
14
FWCI
6.30
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1. https://app.cochat.ai/papers/10.1186/s12943-017-0625-8
The paper
Liu, Y., Liu, R., Yang, F., Cheng, R., Chen, X., Cui, S., Gu, Y., Sun, W., You, C., Liu, Z., Sun, F., Wang, Y., Fu, Z., Ye, C., Zhang, C., Li, J., & Chen, X. (2017). miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1. Molecular Cancer. https://doi.org/10.1186/s12943-017-0625-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.